Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer.

Cancer control : journal of the Moffitt Cancer Center - 1 Jan 2000

Robson Mark E

Abstract excerpt

BACKGROUND: Hereditary predisposition to breast and ovarian cancer, most commonly due to germline mutations in BRCA1 and BRCA2, has been recognized for many years. The optimal clinical management of individuals with such a predisposition is not yet completely defined. METHODS: The current literature regarding the clinical management of individuals at risk for hereditary breast and ovarian cancer was reviewed....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genes, BRCA1
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ovarian Neoplasms

Share to Population Surveillance

Share to Prevalence

Share to Risk Assessment

Share to United States

Source

Identifiers

PMID: 12514563
DOI: 10.1177/107327480200900602

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer.PMID 12514563Read ↗

[Recommendations for treatment of individuals at risk for hereditary breast and ovarian carcinoma].Semantic proximity Read ↗

Identifying and managing hereditary risk of breast and ovarian cancer.Semantic proximity Read ↗

Hereditary breast-ovarian cancer: clinical findings and medical management.Semantic proximity Read ↗

Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer.Semantic proximity Read ↗

Controversies in Hereditary Cancer Management.Semantic proximity Read ↗

Management updates for women with a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Evaluation and management of women with BRCA1/2 mutations.Semantic proximity Read ↗

Management of women who have a genetic predisposition for breast cancer.Semantic proximity Read ↗

The clinical management of BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Hereditary cancer syndromes with high risk of endometrial and ovarian cancer: surgical options for personalized care.Semantic proximity Read ↗

Prevention and Screening in Hereditary Breast and Ovarian Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.